Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | +32.33% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +32.90% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 August 2024
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Appointment of New Director
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust PLC - Blocklisting - Interim Review
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 July 2024
- The Biotech Growth Trust PLC - Result of General Meeting
- The Biotech Growth Trust PLC - Result of AGM
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 30 June 2024
More ▼
Key statistics
As of last trade The Biotech Growth Trust PLC (BIOG:LSE) traded at 1,036.64, -2.57% below its 52-week high of 1,064.00, set on Sep 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 32.07m |
---|---|
Market cap | 335.46m GBP |
Total assets | 382.04m GBP |
Total expense ratio | 1.18% |
High | 1,036.64 |
Low | 1,036.00 |
Previous close | 1,036.00 |
Average volume | 54.99k |
---|---|
YTD Change | +15.96% |
Beta | 0.6242 |
Diluted NAV (est) | 1,127.84 |
Diluted NAV (last pub) | 1,127.22 |
Premium/Discount | -8.14% |
Net Gearing | +4.96% |
Data delayed at least 20 minutes, as of Sep 19 2024 10:06 BST.
More ▼